登录新浪财经APP 搜索【信披】查看更多考评等级 近日，普莱柯生物工程股份有限公司发布关于使用部分闲置募集资金进行现金管理的公告。 经中国证监会核准，普莱柯非公开发行31,420,573股人民币普通股（A股），发行价格为28.58元/股，募 集资金总额为897,999,976.34元，扣除发行费用后净额为885,820,523.22元。公司对募集资金专户管理， 根据使用计划和项目进展，部分资金处于闲置状态。2025年1 - 6月，募集资金使用3,884,676.19元，截 至6月30日，余额为201,103,541.25元。 本次现金管理的基本情况如下： -投资目的：提高闲置募集资金使用效率，确保项目建设和资金安全， 增加投资收益。 -投资额度：不超过2.1亿元，可在额度内单笔或分笔进行单次或累计滚动不超一年期的 现金管理。 -资金来源：部分暂时闲置的募集资金。 -投资品种：安全性高、流动性好的结构性存款、 大额存单等保本型理财产品，不影响项目正常实施。 -投资期限：自第五届董事会第十九次会议、第五 届监事会第十三次会议审议通过之日起12个月内有效。 -投资决策及实施：无需提交股东大会审议，授 权公司法定代表 ...

Core Viewpoint - As of July 11, 2025, the stock price of Xusheng Group (603305) increased by 3.71% to 13.13 CNY, with a market capitalization of 12.517 billion CNY, ranking 39th in the automotive parts sector and 1322nd in the A-share market [1] Company Announcements - The fourth board meeting of Xusheng Group approved two resolutions: the use of up to 1 billion CNY of temporarily idle convertible bond funds for cash management, and the use of up to 500 million CNY of temporarily idle self-owned funds for cash management, both valid for 12 months [2][3] - The supervisory board also approved the same resolutions regarding the use of idle funds for cash management, with unanimous support [2][3] Cash Management Plans - Xusheng Group plans to use up to 1 billion CNY of temporarily idle convertible bond funds for cash management, with a maximum investment period of 12 months, focusing on high-safety and high-liquidity financial products [3] - The cash management will involve the company and its subsidiary, ensuring that the investment does not affect the normal implementation of fundraising projects [3]